In a regulatory filing, AbCellera (ABCL) disclosed hat effective February 18, Dr. Veronique Lecault has transitioned from Chief Operating ...

NASDAQ ABCL opened at $3.27 on Friday. AbCellera Biologics has a 12-month low of $2.34 and a 12-month high of $5.45. The firm’s fifty day simple moving average is $3.06 and its two-hundred day ...

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies ...

ICICI Securities is bullish on Aditya Birla Capital has recommended buy rating on the stock with a target price of Rs 220 in its research report dated 4, 2025.

As the U.S. stock market continues to rally following President Trump's return to office, investors are closely watching the impact of new policies on various sectors. In this context, penny stocks ...

We've been getting creative with the best logo makers for branding your business online. It's difficult to understate the importance of good logo design - it's the quickest way for customers and ...

Want to brand your business without breaking the bank? The best free logo maker will be an essential tool in your marketing kit - and after testing these completely free logo designers ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets ...

Moderna (NASDAQ:MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer ...